Advertisement

Mechanismen der Entstehung genetisch bedingter Krebsformen

  • Siegfried Scherneck
  • Konrad Kölble
Part of the Handbuch der Molekularen Medizin book series (HDBMOLEK, volume 2)

Zusammenfassung

Die Vorstellungen über eine genetische Basis von Tumorerkrankungen, v. a. begründet auf epidemiologischen, zytogenetischen sowie Familienuntersuchungen, lassen sich fast ein ganzes Jahrhundert zurückverfolgen [Wilkowski 1990].

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aaltonen LA, Peltomaki P, Leach FS et al. (1993) Clues to the pathogenesis of familial colorectal cancer. Science 260: 812–816PubMedCrossRefGoogle Scholar
  2. Aaltonen LA, Peltomaki P, Mecklin JP et al. (1994) Replication errors in benign and malignant tumors from hereditary nonpolyposis colorectal cancer patients. Cancer Res 54: 1645–1648PubMedGoogle Scholar
  3. Baker SJ, Fearon ER, Nigro JM et al. (1989) Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 244: 217–221PubMedCrossRefGoogle Scholar
  4. Baker SM, Bronner CE, Zhang L et al. (1995) Male mice defective in the DNA mismatch repair gene PMS2 exhibit abnormal chromosome synapsis in meiosis. Cell 82: 309–319PubMedCrossRefGoogle Scholar
  5. Baker SM, Plug AW, Prolla TA et al. (1996) Involvement of mouse Mlhl in DNA mismatch repair and meiotic crossing over. Nat Genet 13: 336–342PubMedCrossRefGoogle Scholar
  6. Bale SJ, Dracopoli NC, Greene MH et al. (1987) Linkage analysis of melanoma and displastic nevus syndrome with polymorphic loci on human chromosome Ip. Cytogenet Cell Genet 46: 575Google Scholar
  7. Bartow SA, Pathak DR, Black WC et al. (1987) Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. Cancer 60: 2 751–2760Google Scholar
  8. Berg L (1995) Brustkrebs — Wissen gegen Angst. Kunstmann, MünchenGoogle Scholar
  9. Beroud C, Soussi T (1996) APC gene: database of germline and somatic mutations in human tumors and cell lines. Nucleic Acids Res 24: 121–124PubMedCrossRefGoogle Scholar
  10. Bieche I, Lidereau R (1995) Genetic alterations in breast cancer. Genes Chromosom Cancer 14: 227–251PubMedCrossRefGoogle Scholar
  11. Black DM (1994) The genetics of breast cancer. Eur J Cancer 30A: 1957–1961PubMedCrossRefGoogle Scholar
  12. Blaszyk H, Vaughn CB, Hartmann A et al. (1994) Novel pattern of TP53 gene mutations in American black cohort with high mortality from breast cancer. Lancet 1: 1195–1197Google Scholar
  13. Bodmer WF (1994) Cancer genetics. Br Med Bull 50: 517–526PubMedGoogle Scholar
  14. Boland CR, Sato J, Appelman HD et al. (1995) Microallelo typing defines the sequence and tempo of allelic losses at tumour suppressor gene loci during colorectal cancer progression. Nat Med 1: 902–909PubMedCrossRefGoogle Scholar
  15. Bookstein R, Allred DC(1993) Recessive oncogenes. Cancer [Suppl] 71: 1179–1186PubMedCrossRefGoogle Scholar
  16. Borresen AL, Lothe RA, Meling Gl et al. (1995) Somatic mutations in the SH2 gene in microsatellite unstable colorectal carcinomas. Hum Mol Genet 4: 2 065–2072Google Scholar
  17. Bos JL, Fearon ER, Hamilton SR et al. (1987) Prevalence of ras gene mutations in human colorectal cancers. Nature 327: 293–297PubMedCrossRefGoogle Scholar
  18. Boveri T (1914) Zur Frage der Entstehung maligner Tumoren, Bd 1. Fischer, JenaGoogle Scholar
  19. Brash DE, Rudolph JA, Simon JA et al. (1991) A role for sunlight in skin cancer: UV-induced P53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 88: 10124–10128PubMedCrossRefGoogle Scholar
  20. Brentnall TA, Crispin DA, Bronner MP et al. (1996) Microsatellite instability in nonneoplastic mucosa from patients with chronic ulcerative colitis. Cancer Res 56: 1237–1240PubMedGoogle Scholar
  21. Bronner CE, Baker SM, Morrison PT et al. (1994) Mutation in the DNA mismatch repair gene homologue LHl is associated with hereditary non-polyposis colon cancer. Nature 368: 258–261PubMedCrossRefGoogle Scholar
  22. Buchanan JA, Cavenee WK (1987) Genetic markers for assessment of retinoblastoma predisposition. Dis Markers 5: 141–152PubMedGoogle Scholar
  23. Chang-Claude J, Scherneck S (1995) Klonierung des Brustkrebsgens BRCA1. Dtsch Arztebl 92: 2414–2418Google Scholar
  24. Chang-Claude J, Becker H, Hamann M, Schröder-Kurth T (1995) Risikoabschätzung für das familiäre Auftreten von Brustkrebs. Zentralbl Gynakol 117: 432–434Google Scholar
  25. Chong JM, Fukayama M, Hayashi Y et al. (1994) Microsatellite instability in the progression of gastric carcinoma. Cancer Res 54: 4595–4597PubMedGoogle Scholar
  26. Claus EB, Risch N, Thompson WD (1991) Genetic analysis of breast cancer in the cancer and steroid hormone study. Am J Hum Genet 48: 232–242PubMedGoogle Scholar
  27. Cleton-Jansen A-M, Collins N, Lakhani SR et al. (1995) Loss of heterozygosity in sporadic breast tumours at the BRCA2 locus on chromosome 13ql2-ql3. Br J Cancer 72: 1241–1244PubMedCrossRefGoogle Scholar
  28. Cohen PR (1992) Muir-Torre syndrome in patients with hematological malignancies. Am J Hematol 40: 64–65PubMedCrossRefGoogle Scholar
  29. Collins FS (1996) BRCA1 — lots of mutations, lots of dilemmas. N Engl J Med 334: 186–188PubMedCrossRefGoogle Scholar
  30. Collins N, Manus R, Wooster R et al. (1995) Loss of the wildtype chromosome in breast cancer from BRCA2 gene carriers. Oncogene 10: 1673–1675PubMedGoogle Scholar
  31. Cornelis RS, Neuhausen SL, Arason A et al. (1995) High allele loss rates at 17q 12–21 in breast and ovarian tumors from BRCA1 linked families. Genes Chromosom Cancer 13: 203–210PubMedCrossRefGoogle Scholar
  32. Couch FJ, Farid LM, Dhano MC et al. (1996) BRCA2 germline mutations in male breast cancer cases and breast cancer families. Nat Genet 13: 123–125PubMedCrossRefGoogle Scholar
  33. Cowan JM, Halaban R, Francke U (1988) Cytogenetic analysis of melanocytes from premalignant nevi and melanomas. J Natl Cancer Inst 80: 1159–1164PubMedCrossRefGoogle Scholar
  34. Craig-Allred D, O’Connell P, Fuqua SAW et al. (1994) Immunohistochemical studies of early breast cancer evolution. Breast Cancer Res Treat 32: 13–18CrossRefGoogle Scholar
  35. Devilee P, Cornelisse CJ (1994) Somatic genetic changes in human breast cancer. Biochim Biophys Acta 1198: 113–130PubMedGoogle Scholar
  36. Dietrich WF, Lander ES, Smith JS et al. (1993) Genetic identification of Mom-1, a major modifier locus affecting Mininduced intestinal neoplasia in the mouse. Cell 75: 631–639PubMedCrossRefGoogle Scholar
  37. Dix D (1989) The role of ageing in cancer incidence: an epidemiological study. J Gerontol 44: 10–18PubMedGoogle Scholar
  38. Donehower LA (1996) Effects of p53 mutation on tumor progression. Recent insights from mouse tumor models. Biochim Biophys Acta 1242: 171–176PubMedGoogle Scholar
  39. Donehower LA, Harvey M, Slagle BL et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature 356: 215–221PubMedCrossRefGoogle Scholar
  40. Dracopoli N C, Alhadeff B, Houghton AN et al. (1987) Loss of heterozygosity at autosomal and X-linked loci during tumor progression in a patient with melanoma. Cancer Res 47: 3995–4000PubMedGoogle Scholar
  41. Easton DF, Bishop DT, Ford D et al. (1993) Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The breast cancer linkage consortium. Am J Hum Genet 52: 678–701Google Scholar
  42. Faille A, Dremoux P, Extra JM et al. (1994) P53 mutations and overexpression in locally advanced breast cancers. Br J Cancer 69: 1 145–1150Google Scholar
  43. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigenesis. Cell 61: 759–767PubMedCrossRefGoogle Scholar
  44. Fearon ER, Hamilton SR, Vogelstein B (1987) Clonal analysis of human colorectal tumors. Science 238: 193–197PubMedCrossRefGoogle Scholar
  45. Fearon ER, Cho KR, Nigro JM et al. (1990) Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 247: 49–56PubMedCrossRefGoogle Scholar
  46. Felix CA, Strauss EA, D’Amico D et al. (1993) A novel germ line p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene 8: 1203–1210PubMedGoogle Scholar
  47. Feunteun J, Lenoir GM (1996) BRCA1, a gene involved in inherited predisposition to breast and ovarian cancer. Biochim Biophys Acta 1242: 177–180PubMedGoogle Scholar
  48. Fishel R, Kolodner R (1995) Identification of mismatch repair genes and their role in the development of cancer. Curr Opin Genet Dev 5: 382–395PubMedCrossRefGoogle Scholar
  49. Fishel R, Lescoe MK, Rao MRS et al. (1993) The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell 75: 1027–1038PubMedCrossRefGoogle Scholar
  50. Fountain JW, Karayiorgou M, Ernstoff MS et al. (1992) Homozygous deletions within human chromosome band 9p21 in melanoma. Proc Natl Acad Sci USA 89: 10557–10561PubMedCrossRefGoogle Scholar
  51. Frebourg T, Barbier N, Yan Y-X et al. (1995) Germline p53 mutations in 15 families with Li-Fraumeni-Syndrome. Am J Hum Genet 56: 608–615PubMedGoogle Scholar
  52. Friend SH (1996) Breast cancer susceptibility testing: realities in the post-genomic era. Nat Genet 13: 16–17PubMedCrossRefGoogle Scholar
  53. Friend SH, Bernards R, Rogely S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP (1986) A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature 323: 643–646PubMedCrossRefGoogle Scholar
  54. Fujii H, Marsh C, Cairns P et al. (1996) Genetic divergence in the clonal evolution of breast cancer. Cancer Res 56: 1493–1497PubMedGoogle Scholar
  55. Geller G, Bernhard BA, Helzlsouer K (1995) Informed consent and BRCA1 testing. Nat Genet 11: 364PubMedCrossRefGoogle Scholar
  56. Goldstein AM, Goldin LR, Dracopoli NC et al. (1996) Two locus linkage analysis of cutaneous malignant melanoma/ dysplastic nevi. Am J Hum Genet 58: 1050–1056PubMedGoogle Scholar
  57. Goodrich DW, Lee W-H (1993) Molecular characterization of the retinoblastoma susceptibility gene. Biochim Biophys Acta 1 155: 43–61Google Scholar
  58. Greenblatt MS, Bennett WP, Hollstein M et al. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855PubMedGoogle Scholar
  59. Groden J, Thliveris A, Samowitz W et al. (1991) Identification and characterization of the familial adenomatous polyposis coli gene. Cell 66: 589–600PubMedCrossRefGoogle Scholar
  60. Gruis NA, Velden PA van der, Sandkuijl LA et al. (1995) Homozygotes for CDKN2 (pi6) germline mutation in Dutch familial melanoma kindreds. Nat Genet 10: 351–353PubMedCrossRefGoogle Scholar
  61. Hahn A, Schütte M, Hoque AT et al. (1996) A candidate tumor suppressor gene at human chromosome 18q21.1. Science 271: 350–353PubMedCrossRefGoogle Scholar
  62. Hall JM, Zuppan PJ, Anderson LA et al. (1989) Oncogenes and human breast cancer. Am J Hum Genet 44: 577–584PubMedGoogle Scholar
  63. Hall JM, Lee MK, Newman B et al. (1990) Linkage of early onset familial breast cancer to chromosome 17q21. Science 250: 1684–1689PubMedCrossRefGoogle Scholar
  64. Hamilton SR, Liu B, Parsons RE et al. (1995) The molecular basis of Turcot’s syndrome. N Engl J Med 332: 839–847PubMedCrossRefGoogle Scholar
  65. Hansen MF, Cavenee WK (1988) Retinoblastoma and the progression of tumor genetics. Trends Genet 4: 125–128PubMedCrossRefGoogle Scholar
  66. Harada Y, Katagiri T, Ito I et al. (1994) Genetic studies of 475 breast cancer. Clinicopathologic parameters compared with genetic alterations. Cancer 74: 2281–2286Google Scholar
  67. Harris CC (1993) p53: at the crossroads of molecular carcinogenesis and risk assessment. Science 262: 1980–1981PubMedCrossRefGoogle Scholar
  68. Harris CC, Hollstein M (1993) Clinical implications of the p53 tumor suppressor gene. N Engl J Med 329: 1318–1327PubMedCrossRefGoogle Scholar
  69. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266: 1821–1828PubMedCrossRefGoogle Scholar
  70. Hemminki A, Peltomaki P, Mecklin JP et al. (1994) Loss of the wild type MLH1 gene is a feature of hereditary nonpolyposis colorectal cancer. Nat Genet 8: 405–410PubMedCrossRefGoogle Scholar
  71. Herrera L, Kakati S, Gibas L, Pietrzak E, Sandberg AA (1986) Gardner syndrome in a man with an interstitial deletion of 5q. Am J Med Genet 25: 473–476PubMedCrossRefGoogle Scholar
  72. Hirama T, Koeffler HP (1995) Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood 86: 841–854PubMedGoogle Scholar
  73. Horii A, Nakatsuru S, Ichii S et al. (1993) Multiple forms of the APC gene transcripts and their tissue-specific expression. Hum Mol Genet 2: 283–287PubMedCrossRefGoogle Scholar
  74. Hussussian CJ, Struewing JP, Goldstein AM et al. (1994) Germline pl6 mutations in familial melanoma. Nat Genet 1: 15–21CrossRefGoogle Scholar
  75. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M (1993) Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363: 558–561PubMedCrossRefGoogle Scholar
  76. Jass JR, Smyrk TC, Stewart SM et al. (1994) Pathology of hereditary non-polyposis colorectal cancer. Anticancer Res 14: 1631–1634PubMedGoogle Scholar
  77. Jen J, Powell SM, Papadopoulos N et al. (1994) Molecular determinants of dysplasia in colorectal lesions. Cancer Res 54: 5 523–5526Google Scholar
  78. Joslyn G, Carlson M, Thliveris A et al. (1991) Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66: 601–613PubMedCrossRefGoogle Scholar
  79. Kacker RK, Giovanella BC, Pathak S (1990) Consistent karyotypic abnormalities in human malignant melanomas. Anticancer Res 10: 859–872PubMedGoogle Scholar
  80. Kamb A, Gruis NA, Waever-Feldhaus S (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science 264: 436–440PubMedCrossRefGoogle Scholar
  81. Karp JE, Broder S (1995) Molecular foundations of cancer: new targets for intervention. Nat Med 1: 309–320PubMedCrossRefGoogle Scholar
  82. Kerangueven F, Essioux L, Dib A et al. (1995) Loss of heterozygosity and linkage analysis in breast carcinoma: indication for a putative third susceptibility gene on the short arm of chromosome 8. Oncogene 10: 1023–1026PubMedGoogle Scholar
  83. King M-C, Rowell S, Love SM (1993) Inherited breast and ovarian cancer: what are the risks? What are the choices? JAMA 269: 1975–1980PubMedCrossRefGoogle Scholar
  84. Kinzler KW, Nilbert MC, Su LK et al. (1991) Identification of FAP locus genes from chromosome 5q21. Science 253: 661–665PubMedCrossRefGoogle Scholar
  85. Knudson AG (1971) Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820–823PubMedCrossRefGoogle Scholar
  86. Knudson AG (1987) A two-mutation model for human cancer. Advances in viral oncology, vol 7. Raven press, New York, pp 1–17Google Scholar
  87. Knudson AG (1995) Mutations and cancer: a personal Odyssey. Adv Cancer Res 67: 1–23PubMedCrossRefGoogle Scholar
  88. Koh J, Enders GH, Dynlacht BD, Harlow E (1995) Tumour derived pl6 alleles encoding proteins defective in cell-cycle inhibition. Nature 375: 506–510PubMedCrossRefGoogle Scholar
  89. Koonin EV, Altschul SF, Bork P (1996) BRCA1 protein products: functional motifs. Nat Genet 13: 266–267PubMedCrossRefGoogle Scholar
  90. Krontiris TG, Devlin B, Karp DD et al. (1993) An association between the risk of cancer and mutations in the HRAS1 minisatellite locus. N Engl J Med 329: 517–523PubMedCrossRefGoogle Scholar
  91. Kunkel TA (1993) Slippery DNA and diseases. Nature 365: 207–208PubMedCrossRefGoogle Scholar
  92. Law SC, Strong LC, Chidambaram A et al. (1991) A germline mutation in exon 5 of the p53 gene in an extended cancer family. Cancer Res 51: 6385–6387PubMedGoogle Scholar
  93. Lazar V, Grandjouan S, Bognel C et al. (1994) Accumulation of multiple mutations in tumour suppressor genes during colorectal tumorigenesis in HNPCC patients. Hum Mol Genet 3: 2257–2260PubMedCrossRefGoogle Scholar
  94. Leach FS, Nicolaides NC, Papadopoulos N et al. (1993) Mutations of a Mu homolog in hereditary non-polyposis colorectal cancer. Cell 75: 1215–1225PubMedCrossRefGoogle Scholar
  95. Leppert M, Dobbs M, Scambler P et al. (1987) The gene for familial polyposis coli maps to the long arm of chromosome 5. Science 238: 1411–1413PubMedCrossRefGoogle Scholar
  96. Levine AJ (1995) The genetic origins of neoplasia. JAMA 273: 592PubMedCrossRefGoogle Scholar
  97. Levinson G, Gutman GA (1987) High frequencies of short frameshifts in poly-CA/TG tandem repeats borne by bacteriophage M13 in escherichia coli K-12. Nucleic Acids Res 15: 5323–5338PubMedCrossRefGoogle Scholar
  98. Lewis CM, Neuhausen SL, Daley D et al. (1996) Genetic heterogeneity and unmapped genes for colorectal cancer. Cancer Res 56: 1382–1388PubMedGoogle Scholar
  99. Li FP (1993) Molecular epidemiology studies of cancer families. Br J Cancer 68: 217–219PubMedCrossRefGoogle Scholar
  100. Lindblom A, Tannergard P, Werelius B et al. (1993) Genetic mapping of a second locus predisposing to hereditary non-polyposis colon cancer. Nat Genet 5: 279–282PubMedCrossRefGoogle Scholar
  101. Liu B, Farrington SM, Petersen GM et al. (1995a) Genetic instability occurs in the majority of young patients with colorectal cancer. Nat Med 1: 348–352PubMedCrossRefGoogle Scholar
  102. Liu L, Lassam NJ, Slingerland JM et al. (1995b) Germline pl6INK4A mutation and protein dysfunction in a family with inherited melanoma. Oncogene 11: 405–412PubMedGoogle Scholar
  103. Liu B, Parsons R, Papadopoulos N, Nicolaides NC, Lynch HT, Watson P, Jass JR, Dunlop M, Wyllie A, Peltomaki P, Chapelle A de la, Hamilton SR, Vogelstein B, Kinzler KW (1996) Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med 2: 169–174PubMedCrossRefGoogle Scholar
  104. Loeb LA (1994) Microsatellite instability: marker of a mutator phenotype in cancer. Cancer Res 54: 5059–5063PubMedGoogle Scholar
  105. Lohmann DR, Brandt B, Hopping W et al. (1996) The spectrum of Rbl germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58: 940–949PubMedGoogle Scholar
  106. London SJ, Conolly JC, Schnitt SJ et al. (1992) A prospective study of benign breast disease and the risk of breast cancer. JAMA 267: 941–944PubMedCrossRefGoogle Scholar
  107. Lynch HT, Smyrk TC, Watson P et al. (1993) Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review. Gastroenterology 104: 1535–1549PubMedGoogle Scholar
  108. Mahee DG (1995) Mismatch repair, somatic mutations, and the origin of cancer. Cancer Res 55: 5489–5492Google Scholar
  109. Mahee M, Chepenik KP, Liddell RA et al. (1995) The secretory phospholipase A2 gene is a candidate for the moml locus, a major modifier of Apc(Min)-induced intestinal neoplasia. Cell 81: 957–966CrossRefGoogle Scholar
  110. Maliaka YK, Chudina AP, Belev NF et al. (1996) C dinucleotides in the SH2 and LHl genes are hotspots for HNPCC mutations. Hum Genet 97: 251–255PubMedCrossRefGoogle Scholar
  111. Malkin D, Li FP, Strong LC et al. (1990) Germline p53 mutations in a familial syndrome of breast cancer sarcomas and other neoplasms. Science 250: 1233–1238PubMedCrossRefGoogle Scholar
  112. Malkin D (1993) p53 and the Li-Fraumeni-Syndrom. Cancer Genet Cytogenet 66: 83–92PubMedCrossRefGoogle Scholar
  113. Markowitz S, Wang J, Myeroff L et al. (1995) Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 268: 1336–1338PubMedCrossRefGoogle Scholar
  114. Marquis ST, Rajan JV, Wynshaw BA et al. (1995) The developmental pattern of BRCA1 expression implies a role in differentiation of the breast and other tissues. Nat Genet 11: 17–26PubMedCrossRefGoogle Scholar
  115. Marx J (1994) How cells cycle toward cancer. Science 263: 319–321PubMedCrossRefGoogle Scholar
  116. Mathew S, Murty W, Cheifetz S et al. (1994) Transforming growth factor receptor gene TGFBR2 maps to human chromosome band 3p22. Genomics 20: 114–115PubMedCrossRefGoogle Scholar
  117. Mellon I, Champe GN (1996) Products of DNA mismatch repair genes mu and mu are required for transcription-coupled nucleotide-excision repair of the lactose operon in escherichia coli. Proc Natl Acad Sci USA 93: 1292–1297PubMedCrossRefGoogle Scholar
  118. Miki Y, Swensen J, Shattuck-Eidens D et al. (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66–71PubMedCrossRefGoogle Scholar
  119. Milner J (1995) DNA damage, p53 and anticancer therapies. Nat Med 1: 879–880PubMedCrossRefGoogle Scholar
  120. Modrich P (1991) Mechanisms and biological effects of mismatch repair. Annu Rev Genet 25: 229–253PubMedCrossRefGoogle Scholar
  121. Modrich P (1994) Mismatch repair, genetic stability, and cancer. Science 266: 1959–1960PubMedCrossRefGoogle Scholar
  122. Morson BC (1974) The polyp-cancer sequence in the large bowel. Proc R Soc Med 67: 451–457PubMedGoogle Scholar
  123. Munemitsu S, Souza B, Müller O et al. (1994) The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 15: 3676–3681Google Scholar
  124. Nelen MR, Padberg GW, Peeters EAJ et al. (1996) Localization of the gene for Cowden disease to chromosome 10q22-q23. Nat Genet 13: 114–116PubMedCrossRefGoogle Scholar
  125. Neuhausen S, Gilewski T, Norton L et al. (1996) Recurrent BRCA2 6174de mutations in Ashkenazi Jewish woman affected by breast cancer. Nat Genet 13: 126–128PubMedCrossRefGoogle Scholar
  126. Nicolaides NC, Papadopoulos N, Liu B et al. (1994) Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature 371: 75–80PubMedCrossRefGoogle Scholar
  127. Nishisho I, Nakamura Y, Miyoshi Y et al. (1991) Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science 253: 665–669PubMedCrossRefGoogle Scholar
  128. Nobori T, Miura K, Wu DJ et al. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 6473: 753–756CrossRefGoogle Scholar
  129. Nowell P, Hungerford DA (1960) A minute chromosome in human chronic granulocytic leukemia. Science 132: 1497Google Scholar
  130. Palombo F, Gallinari P, Iaccarino I et al. (1995) GTBP, a 160-kilodalton protein essential for mismatch-binding activity in human cells. Science 268: 1912–1914PubMedCrossRefGoogle Scholar
  131. Papadopoulos N, Nicolaides NC, Wie YF et al. (1994) Mutation of a mu homolog in hereditary colon cancer. Science 263: 1625–1629PubMedCrossRefGoogle Scholar
  132. Parsons R, Li GM, Longley MJ et al. (1993) Hypermutability and mismatch repair deficiency in RER(+) tumor cells. Cell 75: 1227–1236PubMedCrossRefGoogle Scholar
  133. Parsons R, Li GM, Longley M (1995) Mismatch repair deficiency in phenotypically normal human cells. Science 268: 738–740PubMedCrossRefGoogle Scholar
  134. Pedersen MI, Wang N (1989) Chromosomal evolution in the progression and metastasis of human malignant melanoma. A multiple lesion study. Cancer Genet Cytogenet 41: 185–201PubMedCrossRefGoogle Scholar
  135. Peinado MA, Malkhosyan S, Velazquez A et al. (1992) Isolation and characterization of allelic losses and gains in colorectal tumors by arbitarily primed polymerase chain reaction. Proc Natl Acad Sci USA 89: 10065–10069PubMedCrossRefGoogle Scholar
  136. Peltomàki P, Aaltonen LA, Sistonen P et al. (1993) Genetic mapping of a locus predisposing to human colorectal cancer. Science 260: 810–812PubMedCrossRefGoogle Scholar
  137. Phelan CM, Lancaster JM, Tonin P et al. (1996) Mutation analysis of the BRCA2 gene in 49 site specific breast cancer families. Nat Genet 13: 120–122PubMedCrossRefGoogle Scholar
  138. Plummer SJ, Casey G (1996) Are we any closer to genetic testing for common malignancies? Nat Med 2: 156–158PubMedCrossRefGoogle Scholar
  139. Ponder PAJ (1990) Inherited predisposition to cancer. Trends Genet 6: 213–221PubMedCrossRefGoogle Scholar
  140. Ponder BA, Wilkinson MM (1986) Direct examination of the clonality of carcinogen-induced colonic epithelial dysplasia in chimeric mice. J Natl Cancer Inst 77: 967–976PubMedGoogle Scholar
  141. Powell SM, Zilz N, Beazer-Barclay Yet al. (1992) APC mutations occur early during colorectal tumorigenesis. Nature 359: 235–237PubMedCrossRefGoogle Scholar
  142. Praml C, Finke LH, Herfarth C et al. (1995a) Deletion mapping defines different regions in lp34.2-pter that may harbor genetic information related to human colorectal cancer. Oncogene 11: 1357–1362PubMedGoogle Scholar
  143. Praml C, Savelyeva L, Le-Paslier D (1995b) Human homologue of a candidate for the Moml locus, the secretory type II phospholipase A2 (PLA2S-II), maps to lp35–36.1/D1S199. Cancer Res 55: 5 504–5506Google Scholar
  144. Puig S, Ruiz A, Lazaro C et al. (1995) 9p Deletions in cutaneous malignant melanoma tumors: the minimal deleted region involves markers outside the pl6 (CDKN2) gene. Am J Hum Genet 57: 395–402PubMedGoogle Scholar
  145. Radford DM, Phillips NS, Fair KL et al. (1995) Allelic loss and the progression of breast cancer. Cancer Res 55: 5180–5183PubMedGoogle Scholar
  146. Ranade K, Hussussian CJ, Sihorski RS et al. (1995) Mutations associated with familial melanoma impair pl6INK4 function. Nat Genet 10: 114–116PubMedCrossRefGoogle Scholar
  147. Reitmair AH, Schmits R, Ewel A et al. (1995) MSH2 deficient mice are viable and susceptible to lymphoid tumours. Nat Genet 11: 64–70PubMedCrossRefGoogle Scholar
  148. Remvikos Y, Vogt N, Muleris M (1995) DNA-repeat instability is associated with colorectal cancers presenting minimal chromosome rearrangements. Genes Chromosom Cancer 12: 272–276PubMedCrossRefGoogle Scholar
  149. Riggins GJ, Markowitz S, Wilson JK et al. (1995) Absence of secretory phospholipase A2 gene alterations in human colorectal cancer. Cancer Res 55: 5184–5186PubMedGoogle Scholar
  150. Rodriquez E, Steekantaiah C, Chaganti RSK (1994) Genetic changes in epithelial solid neoplasia. Cancer Res 54: 3 398–3406Google Scholar
  151. Sager R (1992) Tumor suppressor genes in the cell cycle. Curr Opin Cell Biol 4: 155–160PubMedCrossRefGoogle Scholar
  152. Savitsky K, Bar-Shira A, Gilad S et al. (1995) A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749–1753PubMedCrossRefGoogle Scholar
  153. Scherneck S (1995) Contribution of molecular genetic changes for improved management of breast cancer. Onkologie 18:189–201CrossRefGoogle Scholar
  154. Schlegel J, Stumm G, Scherthan H et al. (1995) Comparative genomic in situ hybridization of colon carcinomas with replication error. Cancer Res 55: 6002–6005PubMedGoogle Scholar
  155. Schneider NR, Williams WR, Chaganti RSK (1986) Genetic epidemiology of familial aggregation of cancer. Adv Cancer Res 47: 1–36PubMedCrossRefGoogle Scholar
  156. Schneider KA, Farkas Patenaude A, Garber JE (1995) Testing for cancer genes: decisions, decisions. Nat Med 1: 302–303.PubMedCrossRefGoogle Scholar
  157. Scott RJ, Krummenacker F, Mary JL et al. (1993) Hereditary p53 mutation in a patient with multiple tumors: significance for genetic counseling. Schweiz Med Wochenschr 25: 1287–1292Google Scholar
  158. Seminara D, Obrams GI (1994) Genetic epidemiology of cancer: a multidisciplinary approach. Genet Epidemiol 11: 235–254PubMedCrossRefGoogle Scholar
  159. Serrano M, Hannon GJ, Beach D (1993) A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature 366: 704–707PubMedCrossRefGoogle Scholar
  160. Shibata D, Peinado MA, Ionov Y et al. (1994) Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation. Nat Genet 6: 273–281PubMedCrossRefGoogle Scholar
  161. Skuse GR, Ludlow JW (1995) Tumour suppressor genes in disease and therapy. Lancet 345: 902–906PubMedCrossRefGoogle Scholar
  162. Smith KJ, Johnson KA, Bryan TM et al. (1993a) The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 90: 2 846–2850CrossRefGoogle Scholar
  163. Smith MR, Matthews NT, Jones KA, Kung H-F (1993b) Biological actions of oncogenes. Pharmacol Ther 58: 211–236PubMedCrossRefGoogle Scholar
  164. Soussi T, Legros Y, Lubin R et al. (1994) Multifactorial analysis of p53 alteration in human cancer. A review. Int J Cancer 57: 1–9PubMedCrossRefGoogle Scholar
  165. Spandidos DA, Liloglou T, Field JF (1993) Prognostic significance of oncogenes and tumor suppressor genes in human malignancy. Stem Cells 11: 194–199PubMedCrossRefGoogle Scholar
  166. Spirio LN, Kutchera W, Winstead MV et al. (1996) Three secretory phospholipase A2 genes that map to human chromosome are not mutated in individuals with attenuated adenomatous polyposis coli. Cancer Res 56: 955–958PubMedGoogle Scholar
  167. Stanbridge EJ (1990) Human tumor suppressor genes. Ann Rev Genet 24: 615–657PubMedCrossRefGoogle Scholar
  168. Stratton MR, Wooster R (1996) Hereditary predisposition to breast cancer. Curr Opin Genet Dev 6: 93–97PubMedCrossRefGoogle Scholar
  169. Strauss M, Lukas J, Bartek J (1995) Unrestricted cell cycling and cancer. Nat Med 1: 1245–1246PubMedCrossRefGoogle Scholar
  170. Struewing JP, Brody LC, Erdos MR et al. (1995) Detection of eight BRCA1 mutations in 10 breast/ovarian cancer families, including one family with male breast cancer. Am J Hum Genet 57: 1–7PubMedGoogle Scholar
  171. Su LK, Kinzler KW, Vogelstein B et al. (1992) Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 256: 668–670PubMedCrossRefGoogle Scholar
  172. Swift M, Chase CL, Morrell D (1990) Cancer predisposition of ataxia-telangiectasia. Cancer Genet Cytogenet 46: 21–27PubMedCrossRefGoogle Scholar
  173. Szabo CI, King M-C (1995) Inherited breast and ovarian cancer. Hum Mol Genet 4: 1811–1817PubMedGoogle Scholar
  174. Tavtigian SV, Simard J, Rommens J et al. (1996) The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet 12: 333–337PubMedCrossRefGoogle Scholar
  175. Thiagalingam S, Lengauer C, Leach FS et al. (1996) Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers. Nat Genet 13: 343–346PubMedCrossRefGoogle Scholar
  176. Thibodeau SN, Bren G, Schaid D (1993) Microsatellite instability in cancer of the proximal colon. Science 260: 816–819PubMedCrossRefGoogle Scholar
  177. Thompson ME, Jensen RA, Obermiller PS et al. (1995) Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 9: 444–450PubMedCrossRefGoogle Scholar
  178. Thorlacius S, Olafsdottir G, Tryggvadottir L et al. (1996) A single BRCA2 mutation in male and female breast cancer families from iceland with varied cancer phenotypes. Nat Genet 13: 117–119PubMedCrossRefGoogle Scholar
  179. Trent JM, Wiltshire R, Su LK et al. (1995) The gene for the APC-binding protein beta-catenin (CTNNB1) maps to chromosome 3p22, a region frequently altered in human malignancies. Cytogenet Cell Genet 71: 343–344PubMedCrossRefGoogle Scholar
  180. Tripathy D, Benz CC (1993) Activated oncogenes and putative tumor suppressor genes involved in human breast cancers. In: Benz CC, Liu ET (eds) Oncogenes and tumor suppressor genes in human malignancies. Kluver, Boston, pp 15–60CrossRefGoogle Scholar
  181. Van de Vijver MC (1993) Molecular genetic changes in human breast cancer. Adv Cancer Res 61: 25–56PubMedCrossRefGoogle Scholar
  182. Vogelstein B, Kinzler KW (1993) The multistep nature of cancer. TIG 9: 138–141PubMedCrossRefGoogle Scholar
  183. Vogelstein B, Fearon ER, Hamilton SR et al. (1988) Genetic alterations during colorectal-tumor development. N Engl J Med 319: 525–532PubMedCrossRefGoogle Scholar
  184. Vogelstein B, Fearon ER, Kern SE et al. (1989) Allelotype of 26 S. Scherneck und K. Kölble: 1.1 Mechanismen der Entstehung genetisch bedingter Krebsformen colorectal carcinomas. Science 244: 207–211PubMedCrossRefGoogle Scholar
  185. Wagner C (1996) Einführung in die Molekulare Onkologie — Veränderungen und Wirkung von Tumorgenen und Tumorproteinen. Thieme, Stuttgart New YorkGoogle Scholar
  186. Walker GJ, Hussussian CJ, Flores JF et al. (1995a) Mutations of the CDKN2/pl6(INK4) gene in Australian melanoma kindreds. Hum Mol Genet 4: 1845–1852PubMedCrossRefGoogle Scholar
  187. Walker GJ, Palmer JM, Walters MK et al. (1995b) A genetic model of melanoma tumorigenesis based on allelic losses. Genes Chromosom Cancer 12: 134–141PubMedCrossRefGoogle Scholar
  188. Weinberg RA (1991) Tumor suppressor genes. Science 254: 1138–1145PubMedCrossRefGoogle Scholar
  189. Whartin AS (1913) Heredity with reference to carcinoma. Arch Intern Med 12: 546–555Google Scholar
  190. Wind N de, Dekker M, Berns A et al. (1995) Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer. Cell 82: 321–330PubMedCrossRefGoogle Scholar
  191. Wilkowski JA (1990) The inherited character of cancer — an historical survey. Cancer Cells 2: 229–257Google Scholar
  192. Wooster R, Mangion J, Eeles R et al. (1992) A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome. Nat Genet 2:132–134PubMedCrossRefGoogle Scholar
  193. Wooster R, Neuhausen SL, Mangion J et al. (1994a) Localization of a breast cancer susceptibility gene, BRCA2, on chromosome 13ql2–13. Science 265: 2088–2090PubMedCrossRefGoogle Scholar
  194. Wooster R, Cleton-Jansen AM, Collins N et al. (1994b) Instability of short tandem repeats (microsatellites) in human cancers. Nat Genet 6: 152–156PubMedCrossRefGoogle Scholar
  195. Wooster R, Bignell G, Lancaster J et al. (1995) Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789–792PubMedCrossRefGoogle Scholar
  196. Wu TH, Marinus MG (1994) Dominant negative mutator mutations in the mu gene of escherichia coli. J Bacteriol 176: 5393–5400PubMedGoogle Scholar
  197. Yamashita H, Kobayashi S, Iwase H et al. (1993) Analysis of oncogenes and tumor suppressor genes in human breast cancer. Jpn J Cancer Res 84: 871–878PubMedCrossRefGoogle Scholar
  198. Young J, Leggett B, Gustafson C et al. (1993) Genomic instability occurs in colorectal carcinomas but not in adenomas. Hum Mutat 2: 351–353PubMedCrossRefGoogle Scholar
  199. Zakian VA (1995) ATM-related genes: what do they tell us about functions of the human gene? Cell 82: 685–687PubMedCrossRefGoogle Scholar
  200. Zhuang Z, Merino MJ, Chuaqui R et al. (1995) Identical allelic loss on chromosome llql3 in microdissected in situ and invasive breast cancer. Cancer Res 55: 467–471PubMedGoogle Scholar
  201. Zuppan P, Hall JM, Lee MK et al. (1991) Possible linkage of the estrogen receptor gene to breast cancer in a family with late-onset of the disease. Am J Hum Genet 48: 1065–1068PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1998

Authors and Affiliations

  • Siegfried Scherneck
  • Konrad Kölble

There are no affiliations available

Personalised recommendations